|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,525.00 KRW | -1.95% |
|
-6.89% | -33.65% |
| 09/12 | GC Genome Study Identifies 'Confounders' Interfering with Cancer Signals to Improve Liquid Biopsy Accuracy | CI |
| 12/06/25 | GC Genome Shares Decline Nearly 3% After Strong Kosdaq Debut | MT |
Business description: GC Genome Corporation

Executive Committee: GC Genome Corporation
| Manager | Title | Age | Since |
|---|---|---|---|
Chang-Seok Gi
CEO | Chief Executive Officer | 57 | 26/03/2020 |
Sang-Hun Jeong
DFI | Director of Finance/CFO | 50 | 27/03/2025 |
Seu-Nga Hyun
AUD | Comptroller/Controller/Auditor | 45 | 29/03/2024 |
Eun-Hae Jo
PRN | Corporate Officer/Principal | 52 | - |
Composition of the Board of Directors: GC Genome Corporation
| Director | Title | Age | Since |
|---|---|---|---|
Sang-Uk Kim
BRD | Director/Board Member | 57 | 30/03/2023 |
Company details: GC Genome Corporation

Medical & Diagnostic Laboratories
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.95% | -6.89% | -48.23% | - | 72.25M | ||
| +1.05% | +0.50% | +73.55% | +481.06% | 39.3B | ||
| -0.87% | -3.39% | +7.01% | +31.72% | 22.77B | ||
| -2.24% | +1.81% | -20.59% | -38.23% | 7.46B | ||
| -7.36% | -4.84% | +13.54% | +106.31% | 5.16B | ||
| +1.88% | +3.79% | +16.99% | +42.79% | 2.88B | ||
| -6.26% | +4.18% | -23.45% | +1,049.26% | 1.95B | ||
| +3.16% | -3.23% | +94.82% | -13.50% | 1.85B | ||
| -1.98% | -10.54% | +24.25% | -26.35% | 1.68B | ||
| +1.82% | -0.63% | +22.02% | -2.73% | 1.62B | ||
| Average | +0.96% | -1.57% | +15.99% | +181.15% | 8.48B | |
| Weighted average by Cap. | +1.09% | -0.36% | +37.97% | +259.60% |
Sector
Annual profits - Rate of surprise
- Stock Market
- Stocks
- A340450 Stock
- Company GC Genome Corporation
Select your edition
All financial news and data tailored to specific country editions

















